President and CEO Maria Sainz reported first quarter revenue of $2.1 million from six system sales, noting this quarter marks the end of a period where the business relied mainly on U.S. hospital ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® ...

Hyperfine’s Swoop system has received FDA clearance and offers AI-powered, point-of-care brain imaging for patients of all ...

GUILFORD, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered ...

Earnings call Hyperfine posted Q4 2025 revenue of $5.3M, up 128% YoY, with gross margin rising to 50.9%. Full-year revenue grew 5% to $13.6M, as second-half launches accelerated growth. Management ...

The MarketWatch News Department was not involved in the creation of this content. Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative ...

Rafael O’Halloran, PhD, and Rob Fasciano, PhD, bring depth and breadth of experience in imaging and Medtech. Rob Fasciano, PhD, joined Hyperfine as Chief Regulatory and Quality Officer, bringing over ...

Hyperfine reported second quarter 2025 results on Aug. 13, highlighting $2.7 million in revenue for the first half of the year, a 26% sequential increase, and the sale of eight systems in the second ...

SAN FRANCISCO--(BUSINESS WIRE)-- Viz.ai, the leading AI-powered disease detection and intelligent care coordination platform, announced today it is partnering with Hyperfine, Inc. (Nasdaq: HYPR), ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance ...